Cough sensors. III. Opioid and cannabinoid receptors on vagal sensory nerves

Handbook of Experimental Pharmacology

Volumn 187, Issue , 2009, Pages 63-76

  Belvisi, M G ^a   Hele, D J ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 [1 (3,4 DICHLORO N METHYLPHENYLACETAMIDO) 2 (1 PYRROLIDINYL)ETHYL]PHENOXYACETIC ACID; 3,4 DICHLORO N METHYL N [1 PHENYL 2 (1 PYRROLIDINYL)ETHYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ALPHA NEOENDORPHIN; BETA ENDORPHIN; BRL 52537; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CB 65; DELTA OPIATE RECEPTOR; DEXANABINOL; DYNORPHIN A; DYNORPHIN B; ENDOMORPHIN 1; ENDOMORPHIN 2; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; JTE 907; KAPPA OPIATE RECEPTOR; L 759633; L 759656; LEUCINE ENKEPHALIN; METENKEPHALIN; MU OPIATE RECEPTOR; N (4 AMINO 2 METHYL 6 QUINOLINYL) 2 (4 ETHYLPHENOXYMETHYL)BENZAMIDE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; N,N DIALLYLTYROSYLGLYCYL ALPHA (2 AMINOETHYLTHIO)HYDROCINNAMOYLLEUCINE; NNC 630532; NOCICEPTIN; O 2050; OPIATE DERIVATIVE; OPIATE RECEPTOR; RIMONABANT; RO 646198; SB 227122; SB 244525; SNC 162; UFP 101; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; COUGHING; GASTROINTESTINAL SYMPTOM; HUMAN; NONHUMAN; OPIATE ADDICTION; PERIPHERAL NERVOUS SYSTEM; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SENSORY NERVE; SIDE EFFECT; TACHYCARDIA; TISSUE DISTRIBUTION; UNITED KINGDOM; VAGUS NERVE; ANIMAL; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSORY NERVE CELL;

ANIMALS; HUMANS; NEURONS, AFFERENT; RECEPTORS, CANNABINOID; RECEPTORS, OPIOID; VAGUS NERVE;

EID: 56049124338     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-79842-2_4     Document Type: Review

References (79)

1. Adcock JJ (1991) Peripheral opioid receptors and the cough reflex. Respir Med 85 (Suppl A):43-46
2. Ambalavanar R, Tanaka Y, Damirjian M et al. (1999) Laryngeal afferent stimulation enhances Fos immunoreactivity in periaqueductal grey in the cat. J Comp Neurol 409:411-423
3. Atweh SF, Kuhar MJ (1977) Autoradiographic localization of opiate receptors in rat brain. II. The brain stem. Brain Res 129:1-12
4. Atweh SF, Murrin LC, Kuhar MJ (1978) Presynaptic localization of opiate receptors in the vagal and accessory optic systems: an autoradiographic study. Neurophamacology 17:65-71
5. Aylward M, Maddock J, Davies DE et al. (1984) Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. Eur J Respir Dis 65:283-291
6. Baekey DM, Morris K, Gestreau C et al. (2001) Medullary respiratory neurones and control of laryngeal motoneurones during fictive eupnoea and cough in the cat. J Physiol 534:565-581
7. Barnes PJ (2001) Neurogenic inflammation in the airways. Respir Physiol 125:145-154
8. Belvisi MG (2002) Overview of the innervation of the lung. Curr Opin Pharmacol 2:211-215
9. Belvisi MG, Bolser D (2002) Summary: animal models for cough. Pulm Pharmacol Ther 15(3):249-250
10. Belvisi MG, Geppetti P (2004) Cough 7: current and future drugs for the treatment of chronic cough. Thorax 59(5):438
11. Belvisi MG, Chung KF, Jackson DM et al. (1988) Opioid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo. Br J Pharmacol 95(2):413-418
12. 4, Gly-ol5] enkephalin, [3H][D-Pen2, D-Pen5]enkephalin, and [3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats. Peptides 18:1603-1608
13. Bolser DC, McLeod RL, Tulshian DB, Hey JA (2001) Antitussive action of nociceptin in the cat. Eur J Pharmacol 430:107-111
14. Braga PC, Fossati A, VimercatiMG, Caputo R, Guffanti EE (1994) Dextrorphan and dextromethorphan: comparative antitussive effects on guinea pigs. Drugs Exp Clin Res 20:199-203
15. Buckley NE, McCoy KL, Mezey E et al. (2000) Immunomodulation by cannabinoids is absent inmice deficient for the cannabinoid CB2 receptor. Eur J Pharmacol 396:141-149
16. Cabot PJ, Crammond T, Smith MT (1996) Quantitative autoradiography of peripheral opioid binding sites in rat lung. Eur J Pharmacol 310:47-53
17. Cabot PJ, Dodd PR, Crammond T et al. (1994) Characterization of non-conventional opioid binding sites in rat and human lung. Eur J Pharmacol 268(2):247-255
18. Cabral GA, Staab A (2005) Effects on the immune system. In: Pertwee RG (ed) Cannabinoids. Handbook of experimental pharmacology, vol. 168. Springer, Berlin, pp 385-423
19. Caligano A, Katano I, Desarnaud F et al. (2000) Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 408(6808):96-101
20. Callaway JK, King RG, Boura AL (1991) Evidence for peripheral mechanisms mediating the antitussive actions of opioids in the guinea pig. Gen Pharmacol 22(6):1103-1108
21. Canning BJ (2007) Encoding of the cough reflex. Pulm Pharmacol Ther 20:396-401
22. Canning BJ, Nori N, Mazzone SB (2006) Vagal afferent nerves regulating the cough reflex. Respir Physiol Neurobiol 152(3):223-242
23. Carr MJ, Lee LY (2006) Plasticity of peripheral mechanisms of cough. Respir Physiol Neurobiol 152(3):298-311
24. Chung KF (2005) Drugs to suppress cough. Expert Opin Investig Drugs 14(1):19-27
25. Chung KF (2007a) Review series: chronic cough: future directions in chronic cough: mechanisms and antitussives. Chron Respir Dis 4(3):159-165
26. Chung KF (2007b) Effective antitussives for the cough patient an unmet need. Pulm Pharmacol Ther 20(4):438-445
27. Clayton N, Marshall FH, Bountra C et al. (2002) CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96:253-260
28. Corboz MR, Fernandez X, Egan RW, Hey JA (2001) Inhibitory activity of nociceptin/orphanin FQ on capsaicin-induced bronchoconstriction in the guinea-pig. Life Sci 69:1203-1211
29. Dashwood MR, Muddle JR, Spyer KM (1988) Opiate receptor subtypes in the nucleus tractus solitarii of the cat: the effect of vagal section. Eur J Pharmacol 155(1-2):85-92
30. Eccles R (2002) The powerful placebo in cough studies? Pulm Pharmacol Ther 15(3):303-308
31. Elmes SJ, Winyard LA, Medhurst SJ et al. (2005) Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat. Pain 118:327-335
32. Fischer A, Forssmann WG, Undem BJ. (1998). Nociceptin-induced inhibition of tachykinergic neurotransmission in guinea pig bronchus. J Pharmacol Exp Ther 285:902-907
33. Fox B, Bull TB, Guz A (1980) Innervation of alveolar walls in the human lung: an electron microscopic study. J Anat 131:683-692
34. Freestone C, Eccles R (1997) Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol 49:1045-1049
35. Frossard N, Barnes PJ (1987) Mu-opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airways. Eur J Pharmacol 141(3):519-522
36. Galiegue S, Mary S, Marchland J et al. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61
37. Gestreau C, Bianchi AL, Grelot L (1997) Differential brainstem Fos-like immunoreactivity after laryngeal-induced coughing and its reduction by codeine. J Neurosci 17:9340-9352
38. Griffin G, Fernando SR, Ross RA et al. (1997) Evidence for the presence of CB2 like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 339:53-61
39. Gundlach A L, Largent BL, Snyder SH (1986) Phencyclidine (PCP) receptors: autoradiographic localization in brain with the selective ligand, [3H]TCP. Brain Res 386:266-279
40. Hanus L, Breuer A, Tchilibon S et al. (1999) HU-308: a specific agonist for CB(2), a peripheralcannabinoid receptor. Proc Natl Acad Sci USA 96:14228-14333
41. Harris J, Drew LJ, Chapman V (2000) Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo. Neuroreport 11:2817-2819
42. Higenbottam T (2002) Chronic cough and the cough reflex in common lung diseases. Pulm Pharmacol Ther 15(3):241-247
43. Howlett AC (2002) The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69:619-631
44. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202
45. Hughes J, Smith TW, Kosterlitz et al. (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577-580
46. Jiang Q, Takemori AE, Sultana M et al. (1991) Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5--isothiocyanate: evidence for delta receptor subtypes. J Pharmacol Exp Ther 257(3):1069-1075
47. Kamei J (2002) Delta-opioid receptor antagonists as a new concept for central acting antitussive drugs. Pulm Pharmacol Ther 15(3):235-240
48. Kamei J, Tanihara H, Kasuya Y (1990) Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats. Eur J Pharmacol 187:281-286
49. Kamei J, Iwamoto Y, Misawa M, Kasuya Y (1993) Effects of rimcazole, a specific antagonistof sigma sites, on the antitussive effects of non-narcotic antitussive drugs. Eur J Pharmacol 242:209-211
50. Karlsson JA, Lanner AS, Persson CG (1990) Airway opioid receptors mediate inhibition of cough and reflex bronchoconstriction in guinea pigs. J Pharmacol Exp Ther 252:863-868
51. Kastelik JA, Aziz I, Ojoo JC et al. (2005) Investigation and management of chronic cough using a probability-based algorithm. Eur Respir J 25(2):235-243
52. Kotzer CJ, Haw DW, Dondio G et al. (2000) The antitussive activity of delta-opioid stimulation in guinea pigs. J Pharmacol Exp Ther 292(2):803-809
53. Lee MG, Undem BJ, Brown C, Carr MJ. (2006) Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs. Am J Respir Crit Care Med 173(3):271-275
54. Lord JA,Waterfield AA, Hughes J et al. (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267:495-499
55. 2 cannabinoid receptors. Chem Phys Lipids 121:191-200
56. Martin WR, Eades CG, Thompson JA et al. (1976) The effects of morphine- and nalorphine-like drugs in nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517-532
57. Matsuda LA, Lolait SJ, Brownstein MJ et al. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
58. McLeod RL, Parra LE, Mutter JC, Erickson CH, Carey GJ, Tulshian DB, Fawzi AB, Smith-Torhan A, Egan RW, Cuss FM et al. (2001) Nociceptin inhibits cough in the guineapig by activation of ORL1 receptors. Br J Pharmacol 132:1175-1178
59. Merick B, Reid L (1971) Nerves in rat intra-acinar alveoli: an electron microscope study. Respir Physiol 11:367-377
60. Morice AH, Menon MS, Mulrennan SA et al. (2007) Opiate therapy in chronic cough. Am J Respir Crit Care Med 175(4):312-315
61. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterisation of a peripheral receptor for cannabinoids. Nature 365:61-65
62. Ohi Y, Yamazaki H, Takeda R et al. (2005) Functional and morphological organization of the nucleus tractus solitarius in the fictive cough reflex of guinea pigs. Neurosci Res 53(2): 201-209
63. Patel HJ, Birrell MA, Crispino N et al. (2003) Inhibition of guinea pig and human sensory nerve activity and the cough reflex in guinea pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol 140:261-268
64. Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74(2):129-180
65. Pertwee RG (2005) Pharmacological actions of cannabinoids. In: Pertwee RG (ed). Cannabinoids.Handbook of experimental pharmacology, vol. 168. Springer, Berlin, pp 1-51
66. Pertwee RG (2007) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids:D9-tetrahydrocannabinol, cannabidiol and D9- tetrahydrocannabivarin. Br J Pharmacol (Sep 10 Epub ahead of print) Pleuvry BJ (2005) Opioid mechanisms and opioid drugs. Anaesth Intensive Care Med 6(1):30-34
67. Porter AC, Felder CC (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther 90:45-60
68. Richardson JD, Aanonsen L, Hargreaves KM (1998a) Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol 345:145-153
69. Richardson JD, Kilo S, Hargreaves KM (1998b) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75:111-119
70. Schroeder K, Fahey T (2002) Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. Br Med J 324:1-6
71. Sessle BJ, Ball GJ, Lucier GE (1981) Suppressive influences from periaqueductal gray and nucleus raphe magnus on respiration and related reflex activities and on solitary tract neurons, and effect of naloxone. Brain Res 216(1):145-161
72. Sevelius H, Colmore JP (1966) Objective assessment of antitussive agents in patients with chroniccough. J New Drugs 6:216-223
73. Sevelius H, McCoy JF, Colmore JP (1971) Dose response to codeine in patients with chronic cough. Clin Pharmacol Ther 12:449-455
74. Shoblock JR (2007) The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity. CNS Drug Rev (Spring) 13(1):107-136
75. Smith J, Owen E, Earis J et al. (2006) Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol 117:831-835
76. Takahama K, Shirasaki T (2007) Central and peripheral mechanisms of narcotic antitussives:codeine-sensitive and -resistant coughs. Cough 3:1-8
77. Undem BJ, Kollarik M (2005) The role of vagal afferent nerves in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2(4):355-360
78. L, Stella N (2004) Cannabinoids and neuroinflammation. Br J Pharmacol 141:775-785
79. Widdicombe JG, Chung KF (2007) Cough. Pulm Pharmacol Ther 20(4):305-306